Andy Pasternak - Jan 4, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP and Chief Business Officer
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Jan 4, 2022
Transactions value $
-$3,006,242
Form type
4
Date filed
1/6/2022, 08:02 PM
Previous filing
Dec 8, 2021
Next filing
Feb 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +48.8K +223.72% 70.7K Jan 5, 2022 Direct F1
transaction HZNP Ordinary Shares Tax liability -$2.21M -21.7K -30.72% $101.84 49K Jan 5, 2022 Direct
transaction HZNP Ordinary Shares Sale -$48.7K -500 -1.02% $97.30 48.5K Jan 6, 2022 Direct F2, F3
transaction HZNP Ordinary Shares Sale -$68.8K -700 -1.44% $98.33 47.8K Jan 6, 2022 Direct F2, F4
transaction HZNP Ordinary Shares Sale -$643K -6.44K -13.48% $99.85 41.3K Jan 6, 2022 Direct F2, F5
transaction HZNP Ordinary Shares Sale -$35K -349 -0.84% $100.23 41K Jan 6, 2022 Direct F2, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units (RSU) Award $0 +23.8K $0.00 23.8K Jan 4, 2022 Ordinary Shares 23.8K Direct F1, F7
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -14.5K -50% $0.00 14.5K Jan 5, 2022 Ordinary Shares 14.5K Direct F1, F8
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -11.6K -33.33% $0.00 23.3K Jan 5, 2022 Ordinary Shares 11.6K Direct F1, F8
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -11.1K -50% $0.00 11.1K Jan 5, 2022 Ordinary Shares 11.1K Direct F1, F9
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -11.6K -66.7% $0.00 5.8K Jan 5, 2022 Ordinary Shares 11.6K Direct F1, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one ordinary share of the Issuer.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.83 to $97.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.95 to $98.79 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.99 to $99.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.05 to $100.62 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The RSU's vest 1/3rd annually on each anniversary of January 5, 2022.
F8 The RSU's vest 1/3rd annually on each anniversary of January 5, 2021.
F9 50% of the shares subject to the RSU's vested on 1/5/2022, and the remaining shares vest on 1/5/2023.
F10 Two-thirds of the ordinary shares subject to the RSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023.